Apyx Medical (APYX) Competitors

$4.17 +0.38 (+9.97%)

As of 01:10 PM Eastern

APYX vs. AVR, TCMD, NPCE, MDXG, and SIBN

Should you buy Apyx Medical stock or one of its competitors? MarketBeat compares Apyx Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Apyx Medical include Anteris Technologies Global (AVR), Tactile Systems Technology (TCMD), NeuroPace (NPCE), MiMedx Group (MDXG), and SiBone (SIBN). These companies are all part of the "medical equipment" industry.

How does Apyx Medical compare to Anteris Technologies Global?

Apyx Medical (NASDAQ:APYX) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

55.3% of Apyx Medical shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Apyx Medical presently has a consensus price target of $6.50, suggesting a potential upside of 55.95%. Anteris Technologies Global has a consensus price target of $16.00, suggesting a potential upside of 78.00%. Given Anteris Technologies Global's higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Apyx Medical has a net margin of -16.40% compared to Anteris Technologies Global's net margin of -5,148.78%. Apyx Medical's return on equity of -88.47% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%

Apyx Medical has higher revenue and earnings than Anteris Technologies Global. Apyx Medical is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$55.90M	3.12	-$11.21M	-$0.22	N/A
Anteris Technologies Global	$1.91M	458.11	-$94.14M	-$2.23	N/A

In the previous week, Anteris Technologies Global had 1 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for Anteris Technologies Global and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.00 beat Anteris Technologies Global's score of -0.08 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Anteris Technologies Global	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Apyx Medical has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market. Comparatively, Anteris Technologies Global has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Summary

Apyx Medical beats Anteris Technologies Global on 12 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Tactile Systems Technology?

Tactile Systems Technology (NASDAQ:TCMD) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

In the previous week, Tactile Systems Technology had 4 more articles in the media than Apyx Medical. MarketBeat recorded 5 mentions for Tactile Systems Technology and 1 mentions for Apyx Medical. Tactile Systems Technology's average media sentiment score of 1.00 beat Apyx Medical's score of 0.00 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tactile Systems Technology has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

83.4% of Tactile Systems Technology shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 2.1% of Tactile Systems Technology shares are owned by insiders. Comparatively, 15.2% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.72	$19.09M	$0.88	28.63
Apyx Medical	$55.90M	3.12	-$11.21M	-$0.22	N/A

Tactile Systems Technology currently has a consensus price target of $38.60, indicating a potential upside of 53.21%. Apyx Medical has a consensus price target of $6.50, indicating a potential upside of 55.95%. Given Apyx Medical's higher possible upside, analysts clearly believe Apyx Medical is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Tactile Systems Technology has a net margin of 5.91% compared to Apyx Medical's net margin of -16.40%. Tactile Systems Technology's return on equity of 9.70% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Apyx Medical	-16.40%	-88.47%	-14.94%

Summary

Tactile Systems Technology beats Apyx Medical on 12 of the 16 factors compared between the two stocks.

How does Apyx Medical compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

NeuroPace presently has a consensus target price of $18.83, suggesting a potential upside of 20.10%. Apyx Medical has a consensus target price of $6.50, suggesting a potential upside of 55.95%. Given Apyx Medical's higher possible upside, analysts clearly believe Apyx Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

Apyx Medical has a net margin of -16.40% compared to NeuroPace's net margin of -21.67%. Apyx Medical's return on equity of -88.47% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.67%	-108.20%	-18.50%
Apyx Medical	-16.40%	-88.47%	-14.94%

NeuroPace has a beta of 1.92, meaning that its stock price is 92% more volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market.

In the previous week, NeuroPace had 13 more articles in the media than Apyx Medical. MarketBeat recorded 14 mentions for NeuroPace and 1 mentions for Apyx Medical. NeuroPace's average media sentiment score of 0.67 beat Apyx Medical's score of 0.00 indicating that NeuroPace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroPace	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

78.8% of NeuroPace shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 20.5% of NeuroPace shares are held by insiders. Comparatively, 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Apyx Medical has lower revenue, but higher earnings than NeuroPace. NeuroPace is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.53M	5.37	-$21.47M	-$0.65	N/A
Apyx Medical	$55.90M	3.12	-$11.21M	-$0.22	N/A

Summary

NeuroPace beats Apyx Medical on 10 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to MiMedx Group?

Apyx Medical (NASDAQ:APYX) and MiMedx Group (NASDAQ:MDXG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 15.2% of Apyx Medical shares are owned by company insiders. Comparatively, 2.5% of MiMedx Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Apyx Medical has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, MiMedx Group has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

MiMedx Group has a net margin of 7.88% compared to Apyx Medical's net margin of -16.40%. MiMedx Group's return on equity of 21.03% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-16.40%	-88.47%	-14.94%
MiMedx Group	7.88%	21.03%	15.92%

In the previous week, MiMedx Group had 3 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for MiMedx Group and 1 mentions for Apyx Medical. MiMedx Group's average media sentiment score of 0.15 beat Apyx Medical's score of 0.00 indicating that MiMedx Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiMedx Group	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Apyx Medical currently has a consensus target price of $6.50, suggesting a potential upside of 55.95%. MiMedx Group has a consensus target price of $8.50, suggesting a potential upside of 138.30%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts plainly believe MiMedx Group is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

MiMedx Group has higher revenue and earnings than Apyx Medical. Apyx Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$55.90M	3.12	-$11.21M	-$0.22	N/A
MiMedx Group	$389.42M	1.36	$48.58M	$0.20	17.84

Summary

MiMedx Group beats Apyx Medical on 14 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to SiBone?

SiBone (NASDAQ:SIBN) and Apyx Medical (NASDAQ:APYX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

In the previous week, SiBone had 3 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for SiBone and 1 mentions for Apyx Medical. SiBone's average media sentiment score of 0.11 beat Apyx Medical's score of 0.00 indicating that SiBone is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SiBone	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Apyx Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

SiBone has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

Apyx Medical has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	3.25	-$18.90M	-$0.39	N/A
Apyx Medical	$55.90M	3.12	-$11.21M	-$0.22	N/A

SiBone presently has a consensus price target of $23.00, suggesting a potential upside of 56.30%. Apyx Medical has a consensus price target of $6.50, suggesting a potential upside of 55.95%. Given SiBone's stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

SiBone has a net margin of -8.10% compared to Apyx Medical's net margin of -16.40%. SiBone's return on equity of -9.56% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-8.10%	-9.56%	-7.06%
Apyx Medical	-16.40%	-88.47%	-14.94%

98.1% of SiBone shares are held by institutional investors. Comparatively, 55.3% of Apyx Medical shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 15.2% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

SiBone beats Apyx Medical on 11 of the 17 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$174.24M	$8.23B	$6.30B	$12.21B
Dividend Yield	N/A	2.52%	2.80%	5.36%
P/E Ratio	-18.91	16.10	20.79	25.32
Price / Sales	3.12	8.52	518.79	71.95
Price / Cash	N/A	16.94	43.18	55.00
Price / Book	13.45	3.97	9.96	6.97
Net Income	-$11.21M	$224.05M	$3.54B	$334.92M
7 Day Performance	-4.40%	2.19%	-0.19%	-0.98%
1 Month Performance	6.87%	4.60%	-0.63%	0.43%
1 Year Performance	181.62%	1.21%	34.10%	33.61%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	2.0346 of 5 stars	$4.17 +10.0%	$6.50 +56.0%	+154.4%	$174.24M	$55.90M	N/A	270
AVR Anteris Technologies Global	2.8779 of 5 stars	$6.70 +2.9%	$15.33 +128.9%	+125.7%	$632.98M	$1.91M	N/A	138
TCMD Tactile Systems Technology	4.2 of 5 stars	$23.53 -1.5%	$38.60 +64.0%	+138.8%	$539.09M	$329.52M	26.74	1,086	Positive News Analyst Forecast
NPCE NeuroPace	3.5887 of 5 stars	$15.80 +0.8%	$18.67 +18.1%	-9.6%	$532M	$99.99M	N/A	170	Analyst Revision
MDXG MiMedx Group	3.8027 of 5 stars	$3.54 -0.6%	$8.50 +140.1%	-47.1%	$530.25M	$418.63M	17.70	870	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. AVR, TCMD, NPCE, MDXG, and SIBN

How does Apyx Medical compare to Anteris Technologies Global?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Summary

How does Apyx Medical compare to NeuroPace?

Summary

How does Apyx Medical compare to MiMedx Group?

Summary

How does Apyx Medical compare to SiBone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. AVR, TCMD, NPCE, MDXG, and SIBN

How does Apyx Medical compare to Anteris Technologies Global?

Do insiders & institutionals hold more shares of APYX or AVR?

Do analysts prefer APYX or AVR?

Is APYX or AVR more profitable?

Which has better valuation & earnings, APYX or AVR?

Does the media refer more to APYX or AVR?

Which has more risk & volatility, APYX or AVR?

Summary

How does Apyx Medical compare to Tactile Systems Technology?

Does the media favor TCMD or APYX?

Which has more volatility and risk, TCMD or APYX?

Do institutionals & insiders believe in TCMD or APYX?

Which has better earnings & valuation, TCMD or APYX?

Do analysts prefer TCMD or APYX?

Is TCMD or APYX more profitable?

Summary

How does Apyx Medical compare to NeuroPace?

Do analysts rate NPCE or APYX?

Is NPCE or APYX more profitable?

Which has more volatility & risk, NPCE or APYX?

Does the media favor NPCE or APYX?

Do insiders and institutionals hold more shares of NPCE or APYX?

Which has higher earnings & valuation, NPCE or APYX?

Summary

How does Apyx Medical compare to MiMedx Group?

Do insiders & institutionals hold more shares of APYX or MDXG?

Which has more volatility & risk, APYX or MDXG?

Is APYX or MDXG more profitable?

Does the media prefer APYX or MDXG?

Do analysts recommend APYX or MDXG?

Which has better valuation & earnings, APYX or MDXG?

Summary

How does Apyx Medical compare to SiBone?

Does the media favor SIBN or APYX?

Which has more volatility & risk, SIBN or APYX?

Which has preferable earnings & valuation, SIBN or APYX?

Do analysts rate SIBN or APYX?

Is SIBN or APYX more profitable?

Do insiders and institutionals believe in SIBN or APYX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools